by Claudia Lutz Next generation DNA sequencing technologies have turned the vision of precision medicine into a plausible reality, but also threaten to overwhelm computing infrastructures with unprecedented volumes of data. A recent $1.3M award from the National Institutes of ...
Read More »Estimation of “sufficient” diversity for learning a molecular signature that is likely to translate to clinical settings
The biomarker discovery field is replete with molecular signatures that have not translated into the clinic despite ostensibly promising performance in predicting disease phenotypes. One widely cited reason is lack of classification consistency, largely due to failure to maintain performance ...
Read More »